2022-12-21T23:44:56-07:00 2021-12-31 990 2021-01-01 203256212 EROWID CENTER EROW 4159633559 PO Box 1116 Grass Valley CA 95945 C Blomquist Treasurer 4159633559 2022-12-21 0 11 0 AAL2 X 2021 2022-09-23 18:48:47Z same as C above PO Box 1116 Grass Valley CA 95945 699750 0 X ErowidCenter.org X 2005 CA To provide & facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues. Erowid also supports and trains information providers and assists medical, legal, and scientific experts in developing resources. 5 3 3 325 0 0 383104 449818 123307 234361 8647 15571 0 0 515058 699750 0 400 0 0 225699 230526 0 0 31754 292430 401653 518129 632579 -3071 67171 583712 785140 1814 1979 581898 783161 X To provide and facilitate access to objective, accurate, and non-judgmental information about psychoactive plants, chemicals, drugs, technologies, and related issues that affect the mind, body, and culture. Erowid Center supports and trains libraries, publishers, and other information distributors on issues related to our field. Further, it is Erowid Center's goal to support medical, legal, scientific, academic, and independent experts in developing and publishing related resources. 0 1 218209 0 206802 1. DrugsData Lab Drug Checking -- Erowid Center runs a laboratory drug checking program that analyzes the contents of samples of psychoactive drugs, including: novel psychoactive substances (NPS); euphoric stimulant tablets and powders (including MDMA/ecstasy/molly); psychedelics, research chemicals; street heroin, fentanyl and other opioids; as well as commercial and counterfeit pharmaceuticals. Samples are tested at a DEA-licensed laboratory and the results are published online at DrugsData.org. Erowid's DrugsData project also collects, manages, reviews, and presents laboratory-testing results from other US and international organizations. This information is made publicly available to help harm-reduction efforts, medical personnel, researchers, and the public. In 2021, there were 1,738 samples tested through the project, nearly double the previous year. These results were published along with those for an additional 638 samples tested by other organizations. An average of 16,000 results were viewed per day, with an average 8,000 unique visitors per day. Results were also regularly published on social media systems with Erowid's more than 100,000 followers. In 2021, Erowid increased its partnerships with research groups doing lab validation of on-site analytical tools such as compact FTIR and fentanyl test strips. [see Schedule O] 82177 0 703 2. Public Online Information Services -- Erowid Center develops, maintains, and provides free access to an online collection of more than 94,000 documents, images, and other media files related to psychoactive plants and drugs. The collection contains information, essays and articles authored by a broad spectrum of contributors including health care professionals, substance abuse counselors, toxicologists, chemists, therapists, law enforcement agents, lawyers, anthropologists, experiential experts, writers, media, educators, and the general public. Note that Erowid's Experience Reports project is tracked as a separate program service. 73065 0 0 3. Archiving of Historical Documents -- Erowid Center's mission includes collecting, organizing, and preserving resources about psychoactives for the historical record. In 2021, Erowid's primary document archiving project was to continue digitizing Alexander and Ann Shulgin's personal papers, photographs, recordings, documents, and books as well as beginning the process of organizing, identifying, and creating metadata for the digitized files. We accepted smaller physical collections of personal papers from anonymous experts in related fields to be organized, indexed, preserved, and eventually made publicly available. Erowid Center continues to maintain and upgrade a physical space designed to allow processing of historical archive collections (organizing, scanning, photographing, and digitizing) as well as permanent storage of such library archives/collections. 39126 0 10884 4. Research, Surveys, & Research Improvement -- In 2021, Erowid co-authored two peer-reviewed journal articles. We also worked on multiple scientific/medical research projects as part of the Lab Validation subproject of our DrugsData program. Erowid improves scientific, medical, and sociological information about psychoactive substances and those who use them by promoting participation in studies and surveys produced by academics, educational institutions, and related organizations. Erowid works directly with scientists-in areas where we have specialized knowledge-to help design credible studies and provide editing, reviewing, and fact-checking for resulting academic publications. Erowid Center's resources are referenced in hundreds of journal articles, books, and media articles each year 38376 0 0 5. Drug Trend & Novel Psychoactive Substance Tracking -- Tracking new psychoactive medicines, technologies, research chemicals, and novel psychoactive substances (NPS) is one of Erowid Center's areas of expertise. With the objective of educating the public on the risks and benefits associated with emerging drugs, we 1) monitor the availability, use patterns, and effects of these substances through consultation with volunteers, allied organizations, medical professionals, submissions, and online forums; 2) analyze psychoactive chemicals through our DrugsData program (tracked as a separate project); 3) coordinate between experts and researchers in the field; 4) educate writers and authors for media, news, and books; and 5) publish information about these substances, online and in print. In 2021, Erowid's DrugsData encountered numerous unidentifiable novel substances in submitted samples. We worked with international experts to identify these substances and publish about their existence. We also partnered with multiple groups look into the shifting contents of street 'heroin'/down/dope/fentanyl as well as cocaine and methamphetamine. Erowid helped identify and characterize contaminants, synthesis byproducts, and novel substances. 34342 0 0 6. Experience Reports Collection -- Erowid Center solicited, reviewed, and published first-hand reports of people's experiences with psychoactive plants, drugs, and technologies. This produced vital information about novel and classic psychoactive materials as well as aggregate data about why and how people use psychoactives, both for current factual documentation and for the historical record. Researchers, academics, medical professionals, and the public use the results for educational purposes and as data for peer-reviewed articles and publications. Reports are reviewed and edited before being published. Trained volunteers perform a portion of the work under the supervision of Erowid staff. In 2021, Erowid crew completed 6,650 "triages" (reading and rating an experience report), published 1,804, and ended the year with 40,636 published reports in the collection covering 861 substances. Approximately 20 million experience reports were viewed during the year. 7. Education 30501 0 14105 7. Education and Educational Materials, Books, and Gifts -- Erowid provided direct education services by answering online questions from the public via email, social media, and other communication systems. Erowid maintains a social media presence via Instagram, Twitter, Facebook, and LinkedIn through which we publish new information, drug checking results, news and research updates, and answer questions related to psychoactives. We distribute books, handouts, and teaching materials about psychoactive drugs, plants, practices, and technologies to members and the general public, furthering our educational mission. 10754 0 0 8. Events & Conferences -- Erowid conducts educational outreach in person and online at conferences, seminars, and festivals. In 2021, we presented and participated in two events, held online. One was an event related to the work of the Shulgins, a pioneering couple in the world of psychedelics. The second was the annual event of the Association for Collaborative Drug Checking, whose members are involved in building, operating, or expanding on-site drug checking and harm reduction programs using on-site technologies. Erowid Center assists by providing lab validation of these results through our DrugsData program. 5667 0 0 9. Information Network - EEN -- Erowid Center works with a network of both professionally trained and self-taught experts with knowledge about psychoactive plants, chemicals, and technologies. Erowid Expert Network (EEN) members volunteer to share their expertise for the purpose of educating the public and improving the quality of information about this topic. The EEN facilitates making connections between those who are seeking information and experts who can help them. This furthers Erowid Center's mission by helping to improve both internal and external educational resources through increased fact checking and review. 4122 0 1867 10. Erowid Extracts Educational Newsletter -- Erowid Center worked on a future newsletter issue centered on public drug checking and our DrugsData laboratory drug checking program (program expenses tracked separately). Initially, this advertisement-free print publication is distributed to members. A complete digital version and constituent articles are later published online for free access by the general public. More than 10,000 copies of previous issues of Erowid Extracts were viewed/downloaded in 2021, and thousands of people read individual articles from previous issues online. Back issues were also distributed worldwide for free to related organizations, members, and events. 162888 0 26856 536339 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 0 1 3 1 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 X 5 3 1 0 0 0 1 1 0 1 1 0 0 1 1 1 1 0 0 1 1 0 CA X X C Blomquist 4159633559 PO Box 1116 Grass Valley CA 95945 C Blomquist Treasurer 60 0 X X 69000 0 13210 B Lincoln President 60 0 X X 69000 0 13210 J Dumpert Secretary 1 0 X X 0 0 0 E Fenster Director 0.7 0 X 0 0 0 S Moore Director 0.5 0 X 0 0 0 138000 0 26420 0 0 0 0 0 0 307351 0 0 37390 105077 0 449818 DrugsData Lab Drug Checking Fees 541380 206802 206802 0 0 Research Fees 541380 14105 14105 0 0 Educational Materials/Books 451211 10884 10884 0 0 Erowid Newsletter 511120 1867 1867 0 0 Online information - referrals 454110 703 703 0 0 0 0 0 0 234361 15571 0 0 15571 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 699750 234361 0 15571 X 400 400 0 0 0 0 0 0 164421 118383 32884 13154 0 0 0 0 46467 45073 929 465 0 0 0 0 4493 4358 90 45 15145 11800 2384 961 0 0 0 0 225 0 225 0 0 0 0 0 0 0 0 0 0 0 780 0 780 0 48107 44130 3557 420 3988 927 0 3061 29628 14831 14639 158 86576 80463 4566 1547 0 0 0 0 21210 15564 3546 2100 3597 2847 393 357 0 0 0 0 1308 1308 0 0 163 0 163 0 0 0 0 0 0 0 0 0 1474 1032 295 147 DrugsData Lab Testing Fees 192750 192750 0 0 Education 10718 2473 35 8210 Postage 1129 0 0 1129 632579 536339 64486 31754 X 24537 24055 61643 56399 0 0 27749 15322 0 0 0 0 0 0 0 0 0 0 0 310004 450355 159779 239009 0 0 0 0 0 0 583712 785140 1814 1979 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1814 1979 X 581898 783161 0 0 0 0 581898 783161 583712 785140 67171 134092 0 0 0 0 X 0 0 0 X 321785 944067 300317 383104 449818 2399091 0 0 0 0 0 0 0 0 0 0 0 321785 944067 300317 383104 449818 2399091 621633 1777458 1429 10651 10767 8647 15571 47065 0 0 0 0 0 0 0 0 0 0 0 0 2446156 533571 0.72663 0.7224 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Bitcoin (BTC) 239009 F 239009 Form 990, Part I, Line 6 Erowid Center has diverse volunteers, from senior researchers to policy makers, health care workers to professors, informed parents to harm-reduction workers, and college-age drug geeks. In 2021, Erowid Center had more than 1,756 volunteers on its volunteer email list, 274 people signed up as volunteer content reviewers, and 25 active Experience Report volunteers. Volunteers reviewed and edited content, found and summarized news stories relevant to our educational mission, tracked drug trends, entered drug checking results, worked to identify unknown substances, visited physical libraries to locate reference materials, helped with archiving projects, and triaged or reviewed Experience Reports. Erowid volunteers contributed more than 1,000 combined hours, though we do not ask volunteers to document their time. Form 990, Part III, Line 3 Impact of SARS-CoV2 Pandemic -- Erowid Center's program services continued to be impacted by SARS-CoV2. Our DrugsData project was negatively affected because it reduced access to street samples for our lab validation research projects. Our archiving team had significantly reduced access to physical source materials from January-November 2021. Also, in-person contact and conferences continued to be limited. Form 990, Part VI, Section A, Line 2 C. Blomquist and B. Lincoln - Family Relationship. Form 990, Part VI, Section A, Line 6 Erowid has a self-electing "Council of Electors" that elects the Board of Directors. The Council of Electors has no other power or duties. Form 990, Part VI, Section A, Line 7a Erowid has a self-electing "Council of Electors" that elects the Board of Directors. The Council of Electors has no other power or duties. Form 990, Part VI, Section B, Line 11b The Treasurer prepared the Form 990 and all associated schedules in cooperation with the Board President. A copy of the completed 990 and all schedules were sent to all members of the Board of Directors prior to filing. No formal review was or will be conducted. Form 990, Part VI, Section B, Line 12c Erowid Center's Conflict of Interest policy covers the officers and Board members of the organization and their families. Every transaction of the organization is reviewed and approved by the Treasurer. The Treasurer reviews any payment to any Board member or key employee for conflicts of interest. Any transactions that might entail a conflict of interest is reviewed by the Board of Directors (minus any interested member). For transactions that involve the Treasurer, such as salary or reimbursement of unusual expenses, approval is sought from an independent committee of the Board. Members of Erowid Center's Board are asked to confirm annually that they comply with this policy. Form 990, Part VI, Section B, Line 15 All officers' salaries and compensation are decided solely by independent members of the Board of Directors based on contemporaneous comparability data for similar positions at similarly situated organizations. The most recent increase in annual compensation for the officers (and all other key employees) was in 2019, when 403(b) retirement plan contributions were implemented. Form 990, Part VI, Section C, Line 18 The organization's governing documents are available on its website, including the IRS Determination Letter, Articles of Incorporation, Bylaws, and Conflict of Interest Policy. The annual financial statements are available upon request as well as through a 3rd party organization's website, GuideStar.org. Form 990, Part VI, Section C, Line 19 The organization's governing documents are available on its website, including the IRS Determination Letter, Articles of Incorporation, Bylaws, and Conflict of Interest Policy. The annual financial statements are available upon request as well as through a 3rd party organization's website, GuideStar.org. Form 990, Part IX, Line 24e Erowid Center's DrugsData project has laboratory fees exceeding 10% of line 25 column A. These are the direct costs of paying an independent DEA-licensed lab for analytical testing services. Form 990, Part X, Line 32 There was a typo on our 2020 990 line 32B "Total net assets or fund balances" at end of year. We have corrected this typo where the number is entered on our 2021 990 line 32A for "beginning of year". We filed form 8868 for automatic extension in February 2022.